טוען...
Lichen planopilaris induced by infliximab: A case report
Infliximab is a tumor necrosis factor-alpha inhibitor used to treat a range of inflammatory diseases. Most reports of cutaneous eruptions from tumor necrosis factor-alpha inhibitors have described the paradoxical development of psoriasis or psoriasiform drug reaction. In our report, we present a 31-...
שמור ב:
| הוצא לאור ב: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6987482/ https://ncbi.nlm.nih.gov/pubmed/32064112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X20901967 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|